PTX 2.44% 4.2¢ prescient therapeutics limited

Ann: FDA grants broader orphan drug status to PTX100 for TCLs, page-10

  1. 3,871 Posts.
    lightbulb Created with Sketch. 3205
    It does bode well for the long term company prospects.

    I wouldn't necessarily relate the pivot a few days ago to this announcement though.

    The pivot was on next to no volume. Secondly the pivot was after the gap between option conversion and heads was almost unprofitable, so it was never going to fall further based on the options expiring alone and was always a very good chance to bounce.

    Fantastic news, gives option holders some relief and every chance of bolstering the PTX coffers for moving on to this next exciting phase.

    I can't speak for the remainder of March with the option expiry due, but I'm quietly excited for the remainder of 2023 and in particular the back end as OmniCar potentially hits veins.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.2¢
Change
0.001(2.44%)
Mkt cap ! $33.82M
Open High Low Value Volume
4.2¢ 4.3¢ 4.1¢ $23.91K 563.5K

Buyers (Bids)

No. Vol. Price($)
1 70733 4.2¢
 

Sellers (Offers)

Price($) Vol. No.
4.3¢ 24822 2
View Market Depth
Last trade - 16.10pm 19/07/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.